nodes	percent_of_prediction	percent_of_DWPC	metapath
Carvedilol—CYP1A1—Omeprazole—Barrett's esophagus	0.165	0.309	CbGbCtD
Carvedilol—CYP1A2—Omeprazole—Barrett's esophagus	0.0736	0.138	CbGbCtD
Carvedilol—CYP2C9—Omeprazole—Barrett's esophagus	0.0664	0.124	CbGbCtD
Carvedilol—CYP3A4—Esomeprazole—Barrett's esophagus	0.0655	0.123	CbGbCtD
Carvedilol—ABCB1—Omeprazole—Barrett's esophagus	0.0644	0.121	CbGbCtD
Carvedilol—CYP2D6—Omeprazole—Barrett's esophagus	0.0607	0.114	CbGbCtD
Carvedilol—CYP3A4—Omeprazole—Barrett's esophagus	0.0386	0.0723	CbGbCtD
Carvedilol—NDUFC2—exocrine gland—Barrett's esophagus	0.00959	0.0955	CbGeAlD
Carvedilol—NPPB—smooth muscle tissue—Barrett's esophagus	0.00796	0.0793	CbGeAlD
Carvedilol—Depression aggravated—Omeprazole—Barrett's esophagus	0.00763	0.0293	CcSEcCtD
Carvedilol—Depression aggravated—Esomeprazole—Barrett's esophagus	0.00763	0.0293	CcSEcCtD
Carvedilol—Leg edema—Omeprazole—Barrett's esophagus	0.00618	0.0237	CcSEcCtD
Carvedilol—Leg edema—Esomeprazole—Barrett's esophagus	0.00618	0.0237	CcSEcCtD
Carvedilol—SELE—epithelium—Barrett's esophagus	0.00558	0.0556	CbGeAlD
Carvedilol—SELE—smooth muscle tissue—Barrett's esophagus	0.00538	0.0536	CbGeAlD
Carvedilol—VCAM1—epithelium—Barrett's esophagus	0.00514	0.0511	CbGeAlD
Carvedilol—VCAM1—smooth muscle tissue—Barrett's esophagus	0.00495	0.0493	CbGeAlD
Carvedilol—HIF1A—epithelium—Barrett's esophagus	0.00494	0.0492	CbGeAlD
Carvedilol—GJA1—epithelium—Barrett's esophagus	0.00479	0.0477	CbGeAlD
Carvedilol—HIF1A—smooth muscle tissue—Barrett's esophagus	0.00476	0.0474	CbGeAlD
Carvedilol—GJA1—smooth muscle tissue—Barrett's esophagus	0.00462	0.046	CbGeAlD
Carvedilol—SELE—digestive system—Barrett's esophagus	0.00425	0.0423	CbGeAlD
Carvedilol—NDUFC2—epithelium—Barrett's esophagus	0.00417	0.0415	CbGeAlD
Carvedilol—Retrosternal pain—Esomeprazole—Barrett's esophagus	0.00414	0.0159	CcSEcCtD
Carvedilol—Retrosternal pain—Omeprazole—Barrett's esophagus	0.00414	0.0159	CcSEcCtD
Carvedilol—VCAM1—digestive system—Barrett's esophagus	0.00391	0.0389	CbGeAlD
Carvedilol—HIF1A—digestive system—Barrett's esophagus	0.00376	0.0374	CbGeAlD
Carvedilol—VEGFA—smooth muscle tissue—Barrett's esophagus	0.00365	0.0363	CbGeAlD
Carvedilol—GJA1—digestive system—Barrett's esophagus	0.00365	0.0363	CbGeAlD
Carvedilol—NDUFC2—digestive system—Barrett's esophagus	0.00317	0.0316	CbGeAlD
Carvedilol—Sleep disturbance—Omeprazole—Barrett's esophagus	0.00297	0.0114	CcSEcCtD
Carvedilol—Sleep disturbance—Esomeprazole—Barrett's esophagus	0.00297	0.0114	CcSEcCtD
Carvedilol—Generalised oedema—Omeprazole—Barrett's esophagus	0.0028	0.0107	CcSEcCtD
Carvedilol—Generalised oedema—Esomeprazole—Barrett's esophagus	0.0028	0.0107	CcSEcCtD
Carvedilol—XDH—digestive system—Barrett's esophagus	0.00256	0.0255	CbGeAlD
Carvedilol—ADRA1D—epithelium—Barrett's esophagus	0.00247	0.0246	CbGeAlD
Carvedilol—Albuminuria—Esomeprazole—Barrett's esophagus	0.00223	0.00856	CcSEcCtD
Carvedilol—Albuminuria—Omeprazole—Barrett's esophagus	0.00223	0.00856	CcSEcCtD
Carvedilol—Rash erythematous—Esomeprazole—Barrett's esophagus	0.00218	0.00835	CcSEcCtD
Carvedilol—Rash erythematous—Omeprazole—Barrett's esophagus	0.00218	0.00835	CcSEcCtD
Carvedilol—Glycosuria—Esomeprazole—Barrett's esophagus	0.00206	0.00789	CcSEcCtD
Carvedilol—Glycosuria—Omeprazole—Barrett's esophagus	0.00206	0.00789	CcSEcCtD
Carvedilol—Accidental injury—Omeprazole—Barrett's esophagus	0.00188	0.00722	CcSEcCtD
Carvedilol—Accidental injury—Esomeprazole—Barrett's esophagus	0.00188	0.00722	CcSEcCtD
Carvedilol—Hyperbilirubinaemia—Esomeprazole—Barrett's esophagus	0.00183	0.00703	CcSEcCtD
Carvedilol—Hyperbilirubinaemia—Omeprazole—Barrett's esophagus	0.00183	0.00703	CcSEcCtD
Carvedilol—Hyperuricaemia—Omeprazole—Barrett's esophagus	0.0018	0.00689	CcSEcCtD
Carvedilol—Hyperuricaemia—Esomeprazole—Barrett's esophagus	0.0018	0.00689	CcSEcCtD
Carvedilol—Creatinine increased—Omeprazole—Barrett's esophagus	0.00175	0.00671	CcSEcCtD
Carvedilol—Creatinine increased—Esomeprazole—Barrett's esophagus	0.00175	0.00671	CcSEcCtD
Carvedilol—Blood uric acid increased—Omeprazole—Barrett's esophagus	0.0017	0.00651	CcSEcCtD
Carvedilol—Blood uric acid increased—Esomeprazole—Barrett's esophagus	0.0017	0.00651	CcSEcCtD
Carvedilol—Phosphatase alkaline increased—Esomeprazole—Barrett's esophagus	0.00167	0.00639	CcSEcCtD
Carvedilol—Phosphatase alkaline increased—Omeprazole—Barrett's esophagus	0.00167	0.00639	CcSEcCtD
Carvedilol—Melaena—Esomeprazole—Barrett's esophagus	0.00163	0.00624	CcSEcCtD
Carvedilol—Melaena—Omeprazole—Barrett's esophagus	0.00163	0.00624	CcSEcCtD
Carvedilol—Fluid retention—Esomeprazole—Barrett's esophagus	0.00158	0.00607	CcSEcCtD
Carvedilol—Fluid retention—Omeprazole—Barrett's esophagus	0.00158	0.00607	CcSEcCtD
Carvedilol—Rash maculo-papular—Esomeprazole—Barrett's esophagus	0.00151	0.00581	CcSEcCtD
Carvedilol—Rash maculo-papular—Omeprazole—Barrett's esophagus	0.00151	0.00581	CcSEcCtD
Carvedilol—Lightheadedness—Esomeprazole—Barrett's esophagus	0.00149	0.00572	CcSEcCtD
Carvedilol—Lightheadedness—Omeprazole—Barrett's esophagus	0.00149	0.00572	CcSEcCtD
Carvedilol—Abnormal vision—Esomeprazole—Barrett's esophagus	0.00145	0.00557	CcSEcCtD
Carvedilol—Abnormal vision—Omeprazole—Barrett's esophagus	0.00145	0.00557	CcSEcCtD
Carvedilol—ADRA1A—epithelium—Barrett's esophagus	0.00142	0.0141	CbGeAlD
Carvedilol—Sleep disorder—Esomeprazole—Barrett's esophagus	0.0014	0.00536	CcSEcCtD
Carvedilol—Sleep disorder—Omeprazole—Barrett's esophagus	0.0014	0.00536	CcSEcCtD
Carvedilol—Blood alkaline phosphatase increased—Omeprazole—Barrett's esophagus	0.00139	0.00533	CcSEcCtD
Carvedilol—Blood alkaline phosphatase increased—Esomeprazole—Barrett's esophagus	0.00139	0.00533	CcSEcCtD
Carvedilol—Swelling—Omeprazole—Barrett's esophagus	0.00137	0.00526	CcSEcCtD
Carvedilol—Swelling—Esomeprazole—Barrett's esophagus	0.00137	0.00526	CcSEcCtD
Carvedilol—Vascular purpura—Omeprazole—Barrett's esophagus	0.00135	0.00519	CcSEcCtD
Carvedilol—Vascular purpura—Esomeprazole—Barrett's esophagus	0.00135	0.00519	CcSEcCtD
Carvedilol—Injury—Esomeprazole—Barrett's esophagus	0.00132	0.00505	CcSEcCtD
Carvedilol—Injury—Omeprazole—Barrett's esophagus	0.00132	0.00505	CcSEcCtD
Carvedilol—Renal impairment—Omeprazole—Barrett's esophagus	0.00127	0.00488	CcSEcCtD
Carvedilol—Renal impairment—Esomeprazole—Barrett's esophagus	0.00127	0.00488	CcSEcCtD
Carvedilol—Purpura—Omeprazole—Barrett's esophagus	0.00125	0.00481	CcSEcCtD
Carvedilol—Purpura—Esomeprazole—Barrett's esophagus	0.00125	0.00481	CcSEcCtD
Carvedilol—Arthritis—Esomeprazole—Barrett's esophagus	0.00124	0.00477	CcSEcCtD
Carvedilol—Arthritis—Omeprazole—Barrett's esophagus	0.00124	0.00477	CcSEcCtD
Carvedilol—Hypoglycaemia—Esomeprazole—Barrett's esophagus	0.00124	0.00475	CcSEcCtD
Carvedilol—Hypoglycaemia—Omeprazole—Barrett's esophagus	0.00124	0.00475	CcSEcCtD
Carvedilol—Hyponatraemia—Esomeprazole—Barrett's esophagus	0.00121	0.00466	CcSEcCtD
Carvedilol—Hyponatraemia—Omeprazole—Barrett's esophagus	0.00121	0.00466	CcSEcCtD
Carvedilol—Pain in extremity—Omeprazole—Barrett's esophagus	0.00121	0.00464	CcSEcCtD
Carvedilol—Gastrointestinal haemorrhage—Esomeprazole—Barrett's esophagus	0.00121	0.00464	CcSEcCtD
Carvedilol—Gastrointestinal haemorrhage—Omeprazole—Barrett's esophagus	0.00121	0.00464	CcSEcCtD
Carvedilol—Pain in extremity—Esomeprazole—Barrett's esophagus	0.00121	0.00464	CcSEcCtD
Carvedilol—Migraine—Omeprazole—Barrett's esophagus	0.00119	0.00457	CcSEcCtD
Carvedilol—Migraine—Esomeprazole—Barrett's esophagus	0.00119	0.00457	CcSEcCtD
Carvedilol—CYP1A1—epithelium—Barrett's esophagus	0.00116	0.0115	CbGeAlD
Carvedilol—Blood creatinine increased—Esomeprazole—Barrett's esophagus	0.00113	0.00435	CcSEcCtD
Carvedilol—Blood creatinine increased—Omeprazole—Barrett's esophagus	0.00113	0.00435	CcSEcCtD
Carvedilol—Hypokalaemia—Esomeprazole—Barrett's esophagus	0.0011	0.00422	CcSEcCtD
Carvedilol—Hypokalaemia—Omeprazole—Barrett's esophagus	0.0011	0.00422	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Omeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Cramp muscle—Esomeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Omeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Cramp muscle—Omeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Aspartate aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Toxic epidermal necrolysis—Esomeprazole—Barrett's esophagus	0.00109	0.00418	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Esomeprazole—Barrett's esophagus	0.00107	0.00409	CcSEcCtD
Carvedilol—Alanine aminotransferase increased—Omeprazole—Barrett's esophagus	0.00107	0.00409	CcSEcCtD
Carvedilol—Influenza—Omeprazole—Barrett's esophagus	0.00105	0.00401	CcSEcCtD
Carvedilol—Influenza—Esomeprazole—Barrett's esophagus	0.00105	0.00401	CcSEcCtD
Carvedilol—Bronchospasm—Esomeprazole—Barrett's esophagus	0.00103	0.00394	CcSEcCtD
Carvedilol—Bronchospasm—Omeprazole—Barrett's esophagus	0.00103	0.00394	CcSEcCtD
Carvedilol—Angina pectoris—Omeprazole—Barrett's esophagus	0.00102	0.00391	CcSEcCtD
Carvedilol—Sweating increased—Esomeprazole—Barrett's esophagus	0.00102	0.00391	CcSEcCtD
Carvedilol—Angina pectoris—Esomeprazole—Barrett's esophagus	0.00102	0.00391	CcSEcCtD
Carvedilol—Sweating increased—Omeprazole—Barrett's esophagus	0.00102	0.00391	CcSEcCtD
Carvedilol—PTGS1—epithelium—Barrett's esophagus	0.00102	0.0101	CbGeAlD
Carvedilol—Pancytopenia—Omeprazole—Barrett's esophagus	0.000992	0.00381	CcSEcCtD
Carvedilol—Pancytopenia—Esomeprazole—Barrett's esophagus	0.000992	0.00381	CcSEcCtD
Carvedilol—PTGS1—smooth muscle tissue—Barrett's esophagus	0.000981	0.00976	CbGeAlD
Carvedilol—Upper respiratory tract infection—Omeprazole—Barrett's esophagus	0.000971	0.00373	CcSEcCtD
Carvedilol—Upper respiratory tract infection—Esomeprazole—Barrett's esophagus	0.000971	0.00373	CcSEcCtD
Carvedilol—Pollakiuria—Esomeprazole—Barrett's esophagus	0.000965	0.0037	CcSEcCtD
Carvedilol—Pollakiuria—Omeprazole—Barrett's esophagus	0.000965	0.0037	CcSEcCtD
Carvedilol—Erectile dysfunction—Esomeprazole—Barrett's esophagus	0.000962	0.00369	CcSEcCtD
Carvedilol—Erectile dysfunction—Omeprazole—Barrett's esophagus	0.000962	0.00369	CcSEcCtD
Carvedilol—Photosensitivity reaction—Omeprazole—Barrett's esophagus	0.000954	0.00366	CcSEcCtD
Carvedilol—Photosensitivity reaction—Esomeprazole—Barrett's esophagus	0.000954	0.00366	CcSEcCtD
Carvedilol—Weight increased—Omeprazole—Barrett's esophagus	0.000951	0.00365	CcSEcCtD
Carvedilol—Weight increased—Esomeprazole—Barrett's esophagus	0.000951	0.00365	CcSEcCtD
Carvedilol—Weight decreased—Esomeprazole—Barrett's esophagus	0.000945	0.00363	CcSEcCtD
Carvedilol—Weight decreased—Omeprazole—Barrett's esophagus	0.000945	0.00363	CcSEcCtD
Carvedilol—Depression—Esomeprazole—Barrett's esophagus	0.000929	0.00357	CcSEcCtD
Carvedilol—Depression—Omeprazole—Barrett's esophagus	0.000929	0.00357	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Esomeprazole—Barrett's esophagus	0.000924	0.00354	CcSEcCtD
Carvedilol—Stevens-Johnson syndrome—Omeprazole—Barrett's esophagus	0.000924	0.00354	CcSEcCtD
Carvedilol—Renal failure—Esomeprazole—Barrett's esophagus	0.000916	0.00351	CcSEcCtD
Carvedilol—Renal failure—Omeprazole—Barrett's esophagus	0.000916	0.00351	CcSEcCtD
Carvedilol—Urinary tract infection—Esomeprazole—Barrett's esophagus	0.000906	0.00348	CcSEcCtD
Carvedilol—Urinary tract infection—Omeprazole—Barrett's esophagus	0.000906	0.00348	CcSEcCtD
Carvedilol—CYP1A2—digestive system—Barrett's esophagus	0.000893	0.0089	CbGeAlD
Carvedilol—Haematuria—Esomeprazole—Barrett's esophagus	0.000888	0.00341	CcSEcCtD
Carvedilol—Haematuria—Omeprazole—Barrett's esophagus	0.000888	0.00341	CcSEcCtD
Carvedilol—CYP1A1—digestive system—Barrett's esophagus	0.000881	0.00878	CbGeAlD
Carvedilol—Sinusitis—Omeprazole—Barrett's esophagus	0.000874	0.00335	CcSEcCtD
Carvedilol—Sinusitis—Esomeprazole—Barrett's esophagus	0.000874	0.00335	CcSEcCtD
Carvedilol—Bradycardia—Omeprazole—Barrett's esophagus	0.000852	0.00327	CcSEcCtD
Carvedilol—Bradycardia—Esomeprazole—Barrett's esophagus	0.000852	0.00327	CcSEcCtD
Carvedilol—CYP2C9—digestive system—Barrett's esophagus	0.000848	0.00845	CbGeAlD
Carvedilol—Rhinitis—Omeprazole—Barrett's esophagus	0.000839	0.00322	CcSEcCtD
Carvedilol—Rhinitis—Esomeprazole—Barrett's esophagus	0.000839	0.00322	CcSEcCtD
Carvedilol—Hypoaesthesia—Esomeprazole—Barrett's esophagus	0.000832	0.00319	CcSEcCtD
Carvedilol—Hypoaesthesia—Omeprazole—Barrett's esophagus	0.000832	0.00319	CcSEcCtD
Carvedilol—Pharyngitis—Omeprazole—Barrett's esophagus	0.00083	0.00319	CcSEcCtD
Carvedilol—Pharyngitis—Esomeprazole—Barrett's esophagus	0.00083	0.00319	CcSEcCtD
Carvedilol—Urinary tract disorder—Esomeprazole—Barrett's esophagus	0.000826	0.00317	CcSEcCtD
Carvedilol—Urinary tract disorder—Omeprazole—Barrett's esophagus	0.000826	0.00317	CcSEcCtD
Carvedilol—Oedema peripheral—Esomeprazole—Barrett's esophagus	0.000824	0.00316	CcSEcCtD
Carvedilol—Oedema peripheral—Omeprazole—Barrett's esophagus	0.000824	0.00316	CcSEcCtD
Carvedilol—Urethral disorder—Omeprazole—Barrett's esophagus	0.00082	0.00315	CcSEcCtD
Carvedilol—Urethral disorder—Esomeprazole—Barrett's esophagus	0.00082	0.00315	CcSEcCtD
Carvedilol—Visual impairment—Omeprazole—Barrett's esophagus	0.000806	0.00309	CcSEcCtD
Carvedilol—Visual impairment—Esomeprazole—Barrett's esophagus	0.000806	0.00309	CcSEcCtD
Carvedilol—CYP2E1—digestive system—Barrett's esophagus	0.000804	0.008	CbGeAlD
Carvedilol—Erythema multiforme—Omeprazole—Barrett's esophagus	0.000791	0.00303	CcSEcCtD
Carvedilol—Erythema multiforme—Esomeprazole—Barrett's esophagus	0.000791	0.00303	CcSEcCtD
Carvedilol—Tinnitus—Esomeprazole—Barrett's esophagus	0.00078	0.00299	CcSEcCtD
Carvedilol—Tinnitus—Omeprazole—Barrett's esophagus	0.00078	0.00299	CcSEcCtD
Carvedilol—PTGS1—digestive system—Barrett's esophagus	0.000774	0.00771	CbGeAlD
Carvedilol—Immune system disorder—Omeprazole—Barrett's esophagus	0.000756	0.0029	CcSEcCtD
Carvedilol—Immune system disorder—Esomeprazole—Barrett's esophagus	0.000756	0.0029	CcSEcCtD
Carvedilol—Mediastinal disorder—Esomeprazole—Barrett's esophagus	0.000754	0.00289	CcSEcCtD
Carvedilol—Mediastinal disorder—Omeprazole—Barrett's esophagus	0.000754	0.00289	CcSEcCtD
Carvedilol—Alopecia—Esomeprazole—Barrett's esophagus	0.000739	0.00284	CcSEcCtD
Carvedilol—Alopecia—Omeprazole—Barrett's esophagus	0.000739	0.00284	CcSEcCtD
Carvedilol—Malnutrition—Esomeprazole—Barrett's esophagus	0.000728	0.00279	CcSEcCtD
Carvedilol—Malnutrition—Omeprazole—Barrett's esophagus	0.000728	0.00279	CcSEcCtD
Carvedilol—Flatulence—Omeprazole—Barrett's esophagus	0.000718	0.00275	CcSEcCtD
Carvedilol—Flatulence—Esomeprazole—Barrett's esophagus	0.000718	0.00275	CcSEcCtD
Carvedilol—Tension—Esomeprazole—Barrett's esophagus	0.000715	0.00274	CcSEcCtD
Carvedilol—Tension—Omeprazole—Barrett's esophagus	0.000715	0.00274	CcSEcCtD
Carvedilol—Nervousness—Omeprazole—Barrett's esophagus	0.000707	0.00271	CcSEcCtD
Carvedilol—Nervousness—Esomeprazole—Barrett's esophagus	0.000707	0.00271	CcSEcCtD
Carvedilol—Back pain—Omeprazole—Barrett's esophagus	0.000704	0.0027	CcSEcCtD
Carvedilol—Back pain—Esomeprazole—Barrett's esophagus	0.000704	0.0027	CcSEcCtD
Carvedilol—Muscle spasms—Omeprazole—Barrett's esophagus	0.0007	0.00269	CcSEcCtD
Carvedilol—Muscle spasms—Esomeprazole—Barrett's esophagus	0.0007	0.00269	CcSEcCtD
Carvedilol—Vision blurred—Esomeprazole—Barrett's esophagus	0.000686	0.00263	CcSEcCtD
Carvedilol—Vision blurred—Omeprazole—Barrett's esophagus	0.000686	0.00263	CcSEcCtD
Carvedilol—Ill-defined disorder—Esomeprazole—Barrett's esophagus	0.000676	0.00259	CcSEcCtD
Carvedilol—Ill-defined disorder—Omeprazole—Barrett's esophagus	0.000676	0.00259	CcSEcCtD
Carvedilol—Anaemia—Esomeprazole—Barrett's esophagus	0.000673	0.00258	CcSEcCtD
Carvedilol—Anaemia—Omeprazole—Barrett's esophagus	0.000673	0.00258	CcSEcCtD
Carvedilol—Angioedema—Omeprazole—Barrett's esophagus	0.000665	0.00255	CcSEcCtD
Carvedilol—Angioedema—Esomeprazole—Barrett's esophagus	0.000665	0.00255	CcSEcCtD
Carvedilol—Malaise—Omeprazole—Barrett's esophagus	0.000657	0.00252	CcSEcCtD
Carvedilol—Malaise—Esomeprazole—Barrett's esophagus	0.000657	0.00252	CcSEcCtD
Carvedilol—Vertigo—Esomeprazole—Barrett's esophagus	0.000654	0.00251	CcSEcCtD
Carvedilol—Vertigo—Omeprazole—Barrett's esophagus	0.000654	0.00251	CcSEcCtD
Carvedilol—Leukopenia—Omeprazole—Barrett's esophagus	0.000652	0.0025	CcSEcCtD
Carvedilol—Leukopenia—Esomeprazole—Barrett's esophagus	0.000652	0.0025	CcSEcCtD
Carvedilol—CYP3A4—digestive system—Barrett's esophagus	0.000647	0.00644	CbGeAlD
Carvedilol—Palpitations—Omeprazole—Barrett's esophagus	0.000643	0.00247	CcSEcCtD
Carvedilol—Palpitations—Esomeprazole—Barrett's esophagus	0.000643	0.00247	CcSEcCtD
Carvedilol—CYP2D6—digestive system—Barrett's esophagus	0.000636	0.00634	CbGeAlD
Carvedilol—Cough—Esomeprazole—Barrett's esophagus	0.000635	0.00244	CcSEcCtD
Carvedilol—Cough—Omeprazole—Barrett's esophagus	0.000635	0.00244	CcSEcCtD
Carvedilol—Hypertension—Omeprazole—Barrett's esophagus	0.000629	0.00241	CcSEcCtD
Carvedilol—Hypertension—Esomeprazole—Barrett's esophagus	0.000629	0.00241	CcSEcCtD
Carvedilol—Arthralgia—Esomeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Chest pain—Esomeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Myalgia—Esomeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Arthralgia—Omeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Myalgia—Omeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Chest pain—Omeprazole—Barrett's esophagus	0.00062	0.00238	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Esomeprazole—Barrett's esophagus	0.000616	0.00236	CcSEcCtD
Carvedilol—Unspecified disorder of skin and subcutaneous tissue—Omeprazole—Barrett's esophagus	0.000616	0.00236	CcSEcCtD
Carvedilol—Discomfort—Esomeprazole—Barrett's esophagus	0.000612	0.00235	CcSEcCtD
Carvedilol—Discomfort—Omeprazole—Barrett's esophagus	0.000612	0.00235	CcSEcCtD
Carvedilol—Dry mouth—Esomeprazole—Barrett's esophagus	0.000606	0.00233	CcSEcCtD
Carvedilol—Dry mouth—Omeprazole—Barrett's esophagus	0.000606	0.00233	CcSEcCtD
Carvedilol—ABCB1—epithelium—Barrett's esophagus	0.000602	0.00599	CbGeAlD
Carvedilol—Confusional state—Omeprazole—Barrett's esophagus	0.000599	0.0023	CcSEcCtD
Carvedilol—Confusional state—Esomeprazole—Barrett's esophagus	0.000599	0.0023	CcSEcCtD
Carvedilol—Anaphylactic shock—Omeprazole—Barrett's esophagus	0.000594	0.00228	CcSEcCtD
Carvedilol—Anaphylactic shock—Esomeprazole—Barrett's esophagus	0.000594	0.00228	CcSEcCtD
Carvedilol—Infection—Omeprazole—Barrett's esophagus	0.00059	0.00227	CcSEcCtD
Carvedilol—Infection—Esomeprazole—Barrett's esophagus	0.00059	0.00227	CcSEcCtD
Carvedilol—Shock—Omeprazole—Barrett's esophagus	0.000585	0.00224	CcSEcCtD
Carvedilol—Shock—Esomeprazole—Barrett's esophagus	0.000585	0.00224	CcSEcCtD
Carvedilol—Thrombocytopenia—Omeprazole—Barrett's esophagus	0.000582	0.00223	CcSEcCtD
Carvedilol—Thrombocytopenia—Esomeprazole—Barrett's esophagus	0.000582	0.00223	CcSEcCtD
Carvedilol—Tachycardia—Esomeprazole—Barrett's esophagus	0.00058	0.00223	CcSEcCtD
Carvedilol—Tachycardia—Omeprazole—Barrett's esophagus	0.00058	0.00223	CcSEcCtD
Carvedilol—Skin disorder—Omeprazole—Barrett's esophagus	0.000577	0.00222	CcSEcCtD
Carvedilol—Skin disorder—Esomeprazole—Barrett's esophagus	0.000577	0.00222	CcSEcCtD
Carvedilol—Hyperhidrosis—Esomeprazole—Barrett's esophagus	0.000575	0.0022	CcSEcCtD
Carvedilol—Hyperhidrosis—Omeprazole—Barrett's esophagus	0.000575	0.0022	CcSEcCtD
Carvedilol—Anorexia—Omeprazole—Barrett's esophagus	0.000566	0.00217	CcSEcCtD
Carvedilol—Anorexia—Esomeprazole—Barrett's esophagus	0.000566	0.00217	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Esomeprazole—Barrett's esophagus	0.000541	0.00208	CcSEcCtD
Carvedilol—Musculoskeletal discomfort—Omeprazole—Barrett's esophagus	0.000541	0.00208	CcSEcCtD
Carvedilol—Insomnia—Esomeprazole—Barrett's esophagus	0.000537	0.00206	CcSEcCtD
Carvedilol—Insomnia—Omeprazole—Barrett's esophagus	0.000537	0.00206	CcSEcCtD
Carvedilol—Paraesthesia—Esomeprazole—Barrett's esophagus	0.000534	0.00205	CcSEcCtD
Carvedilol—Paraesthesia—Omeprazole—Barrett's esophagus	0.000534	0.00205	CcSEcCtD
Carvedilol—Dyspnoea—Esomeprazole—Barrett's esophagus	0.00053	0.00203	CcSEcCtD
Carvedilol—Dyspnoea—Omeprazole—Barrett's esophagus	0.00053	0.00203	CcSEcCtD
Carvedilol—Somnolence—Esomeprazole—Barrett's esophagus	0.000528	0.00203	CcSEcCtD
Carvedilol—Somnolence—Omeprazole—Barrett's esophagus	0.000528	0.00203	CcSEcCtD
Carvedilol—Dyspepsia—Esomeprazole—Barrett's esophagus	0.000523	0.00201	CcSEcCtD
Carvedilol—Dyspepsia—Omeprazole—Barrett's esophagus	0.000523	0.00201	CcSEcCtD
Carvedilol—Decreased appetite—Esomeprazole—Barrett's esophagus	0.000517	0.00198	CcSEcCtD
Carvedilol—Decreased appetite—Omeprazole—Barrett's esophagus	0.000517	0.00198	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Esomeprazole—Barrett's esophagus	0.000513	0.00197	CcSEcCtD
Carvedilol—Gastrointestinal disorder—Omeprazole—Barrett's esophagus	0.000513	0.00197	CcSEcCtD
Carvedilol—Fatigue—Omeprazole—Barrett's esophagus	0.000512	0.00197	CcSEcCtD
Carvedilol—Fatigue—Esomeprazole—Barrett's esophagus	0.000512	0.00197	CcSEcCtD
Carvedilol—Pain—Esomeprazole—Barrett's esophagus	0.000508	0.00195	CcSEcCtD
Carvedilol—Constipation—Esomeprazole—Barrett's esophagus	0.000508	0.00195	CcSEcCtD
Carvedilol—Pain—Omeprazole—Barrett's esophagus	0.000508	0.00195	CcSEcCtD
Carvedilol—Constipation—Omeprazole—Barrett's esophagus	0.000508	0.00195	CcSEcCtD
Carvedilol—Feeling abnormal—Esomeprazole—Barrett's esophagus	0.00049	0.00188	CcSEcCtD
Carvedilol—Feeling abnormal—Omeprazole—Barrett's esophagus	0.00049	0.00188	CcSEcCtD
Carvedilol—Gastrointestinal pain—Esomeprazole—Barrett's esophagus	0.000486	0.00186	CcSEcCtD
Carvedilol—Gastrointestinal pain—Omeprazole—Barrett's esophagus	0.000486	0.00186	CcSEcCtD
Carvedilol—Urticaria—Omeprazole—Barrett's esophagus	0.000472	0.00181	CcSEcCtD
Carvedilol—Urticaria—Esomeprazole—Barrett's esophagus	0.000472	0.00181	CcSEcCtD
Carvedilol—Abdominal pain—Omeprazole—Barrett's esophagus	0.00047	0.0018	CcSEcCtD
Carvedilol—Body temperature increased—Omeprazole—Barrett's esophagus	0.00047	0.0018	CcSEcCtD
Carvedilol—Abdominal pain—Esomeprazole—Barrett's esophagus	0.00047	0.0018	CcSEcCtD
Carvedilol—Body temperature increased—Esomeprazole—Barrett's esophagus	0.00047	0.0018	CcSEcCtD
Carvedilol—ABCB1—digestive system—Barrett's esophagus	0.000458	0.00456	CbGeAlD
Carvedilol—Hypersensitivity—Esomeprazole—Barrett's esophagus	0.000438	0.00168	CcSEcCtD
Carvedilol—Hypersensitivity—Omeprazole—Barrett's esophagus	0.000438	0.00168	CcSEcCtD
Carvedilol—Asthenia—Esomeprazole—Barrett's esophagus	0.000426	0.00164	CcSEcCtD
Carvedilol—Asthenia—Omeprazole—Barrett's esophagus	0.000426	0.00164	CcSEcCtD
Carvedilol—Pruritus—Omeprazole—Barrett's esophagus	0.00042	0.00161	CcSEcCtD
Carvedilol—Pruritus—Esomeprazole—Barrett's esophagus	0.00042	0.00161	CcSEcCtD
Carvedilol—Diarrhoea—Esomeprazole—Barrett's esophagus	0.000407	0.00156	CcSEcCtD
Carvedilol—Diarrhoea—Omeprazole—Barrett's esophagus	0.000407	0.00156	CcSEcCtD
Carvedilol—Dizziness—Omeprazole—Barrett's esophagus	0.000393	0.00151	CcSEcCtD
Carvedilol—Dizziness—Esomeprazole—Barrett's esophagus	0.000393	0.00151	CcSEcCtD
Carvedilol—Vomiting—Omeprazole—Barrett's esophagus	0.000378	0.00145	CcSEcCtD
Carvedilol—Vomiting—Esomeprazole—Barrett's esophagus	0.000378	0.00145	CcSEcCtD
Carvedilol—Rash—Esomeprazole—Barrett's esophagus	0.000375	0.00144	CcSEcCtD
Carvedilol—Rash—Omeprazole—Barrett's esophagus	0.000375	0.00144	CcSEcCtD
Carvedilol—Dermatitis—Omeprazole—Barrett's esophagus	0.000374	0.00144	CcSEcCtD
Carvedilol—Dermatitis—Esomeprazole—Barrett's esophagus	0.000374	0.00144	CcSEcCtD
Carvedilol—Headache—Esomeprazole—Barrett's esophagus	0.000372	0.00143	CcSEcCtD
Carvedilol—Headache—Omeprazole—Barrett's esophagus	0.000372	0.00143	CcSEcCtD
Carvedilol—Nausea—Esomeprazole—Barrett's esophagus	0.000353	0.00135	CcSEcCtD
Carvedilol—Nausea—Omeprazole—Barrett's esophagus	0.000353	0.00135	CcSEcCtD
Carvedilol—XDH—Metabolism—CYP26A1—Barrett's esophagus	0.000115	0.0011	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—SST—Barrett's esophagus	0.000114	0.00108	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—CDKN2A—Barrett's esophagus	0.000113	0.00107	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	0.000112	0.00107	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—HGF—Barrett's esophagus	0.000111	0.00106	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.00011	0.00105	CbGpPWpGaD
Carvedilol—CYP3A4—Biological oxidations—CYP26A1—Barrett's esophagus	0.000109	0.00104	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—RELA—Barrett's esophagus	0.000108	0.00103	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—RELA—Barrett's esophagus	0.000108	0.00103	CbGpPWpGaD
Carvedilol—CYP3A4—Metapathway biotransformation—CYP26A1—Barrett's esophagus	0.000108	0.00103	CbGpPWpGaD
Carvedilol—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Barrett's esophagus	0.000105	0.001	CbGpPWpGaD
Carvedilol—CYP1A1—PPARA activates gene expression—PPARG—Barrett's esophagus	0.000104	0.000994	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—SST—Barrett's esophagus	0.000104	0.000986	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—SST—Barrett's esophagus	0.000103	0.000977	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—SST—Barrett's esophagus	0.000102	0.000974	CbGpPWpGaD
Carvedilol—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARG—Barrett's esophagus	0.000102	0.000973	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—CXCL8—Barrett's esophagus	0.000102	0.000972	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—SST—Barrett's esophagus	0.000101	0.000965	CbGpPWpGaD
Carvedilol—ADRA1B—AMPK Signaling—TP53—Barrett's esophagus	9.93e-05	0.000946	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—SST—Barrett's esophagus	9.86e-05	0.000939	CbGpPWpGaD
Carvedilol—CYP1A2—Arachidonic acid metabolism—PTGS2—Barrett's esophagus	9.83e-05	0.000937	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Breast Cancer Pathway—TP53—Barrett's esophagus	9.79e-05	0.000933	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—PPARG—Barrett's esophagus	9.69e-05	0.000923	CbGpPWpGaD
Carvedilol—ADRA2A—Platelet activation, signaling and aggregation—HGF—Barrett's esophagus	9.62e-05	0.000917	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—SST—Barrett's esophagus	9.58e-05	0.000913	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—SST—Barrett's esophagus	9.43e-05	0.000899	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—GAST—Barrett's esophagus	9.37e-05	0.000893	CbGpPWpGaD
Carvedilol—HIF1A—Disease—APC—Barrett's esophagus	9.24e-05	0.00088	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—SST—Barrett's esophagus	8.95e-05	0.000853	CbGpPWpGaD
Carvedilol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	8.92e-05	0.00085	CbGpPWpGaD
Carvedilol—VCAM1—Immune System—RELA—Barrett's esophagus	8.82e-05	0.000841	CbGpPWpGaD
Carvedilol—ADRA1A—AMPK Signaling—TP53—Barrett's esophagus	8.82e-05	0.00084	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—GAST—Barrett's esophagus	8.54e-05	0.000813	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—GAST—Barrett's esophagus	8.51e-05	0.000811	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—GAST—Barrett's esophagus	8.46e-05	0.000806	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	8.38e-05	0.000799	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—SST—Barrett's esophagus	8.38e-05	0.000798	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—GAST—Barrett's esophagus	8.35e-05	0.000796	CbGpPWpGaD
Carvedilol—XDH—Metabolism—SLC9A1—Barrett's esophagus	8.29e-05	0.000789	CbGpPWpGaD
Carvedilol—ABCB1—Allograft Rejection—CXCL8—Barrett's esophagus	8.28e-05	0.000789	CbGpPWpGaD
Carvedilol—VEGFA—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	8.11e-05	0.000773	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—PPARG—Barrett's esophagus	8.1e-05	0.000772	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—GAST—Barrett's esophagus	7.9e-05	0.000753	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—SST—Barrett's esophagus	7.78e-05	0.000742	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—GAST—Barrett's esophagus	7.78e-05	0.000741	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—GAST—Barrett's esophagus	7.75e-05	0.000739	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—GAST—Barrett's esophagus	7.72e-05	0.000735	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—GAST—Barrett's esophagus	7.7e-05	0.000734	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—GAST—Barrett's esophagus	7.68e-05	0.000732	CbGpPWpGaD
Carvedilol—NDUFC2—Metabolism—PTGS2—Barrett's esophagus	7.62e-05	0.000726	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—ATP4A—Barrett's esophagus	7.6e-05	0.000724	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—GAST—Barrett's esophagus	7.58e-05	0.000722	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—GAST—Barrett's esophagus	7.18e-05	0.000684	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGES—Barrett's esophagus	7.16e-05	0.000682	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGES—Barrett's esophagus	7.11e-05	0.000678	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGES—Barrett's esophagus	7.1e-05	0.000676	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—GAST—Barrett's esophagus	7.06e-05	0.000673	CbGpPWpGaD
Carvedilol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARG—Barrett's esophagus	7.04e-05	0.00067	CbGpPWpGaD
Carvedilol—HIF1A—Disease—PTGS2—Barrett's esophagus	7.01e-05	0.000668	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—GAST—Barrett's esophagus	6.91e-05	0.000658	CbGpPWpGaD
Carvedilol—ADRB3—GPCR ligand binding—CXCL8—Barrett's esophagus	6.8e-05	0.000647	CbGpPWpGaD
Carvedilol—ADRA2B—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.6e-05	0.000629	CbGpPWpGaD
Carvedilol—VEGFA—Developmental Biology—RELA—Barrett's esophagus	6.56e-05	0.000625	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—HGF—Barrett's esophagus	6.54e-05	0.000623	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—APC—Barrett's esophagus	6.47e-05	0.000616	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—SST—Barrett's esophagus	6.42e-05	0.000612	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—GAST—Barrett's esophagus	6.42e-05	0.000611	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—GAST—Barrett's esophagus	6.27e-05	0.000598	CbGpPWpGaD
Carvedilol—VEGFA—Cellular responses to stress—TP53—Barrett's esophagus	6.26e-05	0.000597	CbGpPWpGaD
Carvedilol—ADRA2C—G alpha (i) signalling events—CXCL8—Barrett's esophagus	6.17e-05	0.000587	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—HGF—Barrett's esophagus	6.11e-05	0.000582	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—SST—Barrett's esophagus	5.85e-05	0.000557	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—SST—Barrett's esophagus	5.83e-05	0.000556	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—GAST—Barrett's esophagus	5.83e-05	0.000555	CbGpPWpGaD
Carvedilol—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.81e-05	0.000554	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—SST—Barrett's esophagus	5.8e-05	0.000552	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGES—Barrett's esophagus	5.78e-05	0.000551	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—SST—Barrett's esophagus	5.72e-05	0.000545	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—APC—Barrett's esophagus	5.55e-05	0.000529	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—SST—Barrett's esophagus	5.42e-05	0.000516	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—CYP26A1—Barrett's esophagus	5.39e-05	0.000514	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—CYP26A1—Barrett's esophagus	5.38e-05	0.000513	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—SST—Barrett's esophagus	5.33e-05	0.000508	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—SST—Barrett's esophagus	5.31e-05	0.000506	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGES—Barrett's esophagus	5.31e-05	0.000506	CbGpPWpGaD
Carvedilol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.3e-05	0.000505	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—SST—Barrett's esophagus	5.29e-05	0.000504	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—SST—Barrett's esophagus	5.28e-05	0.000503	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—SST—Barrett's esophagus	5.27e-05	0.000502	CbGpPWpGaD
Carvedilol—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.25e-05	0.0005	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—SST—Barrett's esophagus	5.2e-05	0.000495	CbGpPWpGaD
Carvedilol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	5.18e-05	0.000494	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—RELA—Barrett's esophagus	5.06e-05	0.000482	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—GAST—Barrett's esophagus	5.03e-05	0.000479	CbGpPWpGaD
Carvedilol—ADRA2A—G alpha (i) signalling events—CXCL8—Barrett's esophagus	5.01e-05	0.000477	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGES—Barrett's esophagus	5e-05	0.000477	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—HGF—Barrett's esophagus	4.96e-05	0.000472	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—SST—Barrett's esophagus	4.92e-05	0.000469	CbGpPWpGaD
Carvedilol—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.9e-05	0.000467	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—SST—Barrett's esophagus	4.84e-05	0.000461	CbGpPWpGaD
Carvedilol—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.83e-05	0.00046	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—CXCL8—Barrett's esophagus	4.76e-05	0.000454	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—SST—Barrett's esophagus	4.73e-05	0.000451	CbGpPWpGaD
Carvedilol—ABCB1—Transmembrane transport of small molecules—SLC9A1—Barrett's esophagus	4.66e-05	0.000444	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—GAST—Barrett's esophagus	4.58e-05	0.000436	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—GAST—Barrett's esophagus	4.54e-05	0.000432	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—GAST—Barrett's esophagus	4.48e-05	0.000427	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR ligand binding—CXCL8—Barrett's esophagus	4.43e-05	0.000422	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—SST—Barrett's esophagus	4.4e-05	0.000419	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—CYP26A1—Barrett's esophagus	4.38e-05	0.000417	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—SST—Barrett's esophagus	4.3e-05	0.00041	CbGpPWpGaD
Carvedilol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	4.29e-05	0.000408	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—GAST—Barrett's esophagus	4.24e-05	0.000404	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—Barrett's esophagus	4.22e-05	0.000402	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—GAST—Barrett's esophagus	4.17e-05	0.000397	CbGpPWpGaD
Carvedilol—ADRB1—GPCR ligand binding—CXCL8—Barrett's esophagus	4.03e-05	0.000384	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—CYP26A1—Barrett's esophagus	4.02e-05	0.000383	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR ligand binding—CXCL8—Barrett's esophagus	4e-05	0.000381	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGES—Barrett's esophagus	4e-05	0.000381	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—SST—Barrett's esophagus	3.99e-05	0.000381	CbGpPWpGaD
Carvedilol—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Barrett's esophagus	3.98e-05	0.000379	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	3.98e-05	0.000379	CbGpPWpGaD
Carvedilol—ADRB2—GPCR ligand binding—CXCL8—Barrett's esophagus	3.95e-05	0.000376	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—SLC9A1—Barrett's esophagus	3.89e-05	0.00037	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—SLC9A1—Barrett's esophagus	3.88e-05	0.00037	CbGpPWpGaD
Carvedilol—ADRB3—GPCR downstream signaling—CXCL8—Barrett's esophagus	3.84e-05	0.000366	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—CYP26A1—Barrett's esophagus	3.79e-05	0.000361	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PPARG—Barrett's esophagus	3.78e-05	0.00036	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGES—Barrett's esophagus	3.77e-05	0.000359	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR ligand binding—CXCL8—Barrett's esophagus	3.73e-05	0.000356	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGES—Barrett's esophagus	3.73e-05	0.000356	CbGpPWpGaD
Carvedilol—VEGFA—Hemostasis—TP53—Barrett's esophagus	3.72e-05	0.000355	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—GAST—Barrett's esophagus	3.71e-05	0.000353	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR ligand binding—CXCL8—Barrett's esophagus	3.67e-05	0.00035	CbGpPWpGaD
Carvedilol—ADRB3—Signaling by GPCR—CXCL8—Barrett's esophagus	3.49e-05	0.000332	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—SST—Barrett's esophagus	3.45e-05	0.000328	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—GAST—Barrett's esophagus	3.44e-05	0.000328	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR ligand binding—CXCL8—Barrett's esophagus	3.26e-05	0.000311	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGES—Barrett's esophagus	3.19e-05	0.000304	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—SLC9A1—Barrett's esophagus	3.16e-05	0.000301	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—SST—Barrett's esophagus	3.14e-05	0.000299	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	3.13e-05	0.000298	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—SST—Barrett's esophagus	3.11e-05	0.000296	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—SST—Barrett's esophagus	3.07e-05	0.000293	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR ligand binding—CXCL8—Barrett's esophagus	3.03e-05	0.000289	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—CYP26A1—Barrett's esophagus	3.03e-05	0.000289	CbGpPWpGaD
Carvedilol—XDH—Metabolism—PTGS2—Barrett's esophagus	2.98e-05	0.000283	CbGpPWpGaD
Carvedilol—HIF1A—Signaling Pathways—TP53—Barrett's esophagus	2.92e-05	0.000279	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—SST—Barrett's esophagus	2.91e-05	0.000277	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—SLC9A1—Barrett's esophagus	2.9e-05	0.000276	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—SST—Barrett's esophagus	2.86e-05	0.000272	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—CYP26A1—Barrett's esophagus	2.85e-05	0.000272	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—CYP26A1—Barrett's esophagus	2.83e-05	0.00027	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.8e-05	0.000267	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—APC—Barrett's esophagus	2.8e-05	0.000267	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—APC—Barrett's esophagus	2.79e-05	0.000266	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—SLC9A1—Barrett's esophagus	2.73e-05	0.00026	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—SST—Barrett's esophagus	2.54e-05	0.000242	CbGpPWpGaD
Carvedilol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—Barrett's esophagus	2.51e-05	0.000239	CbGpPWpGaD
Carvedilol—ADRA1D—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.5e-05	0.000238	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGES—Barrett's esophagus	2.46e-05	0.000235	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—CYP26A1—Barrett's esophagus	2.42e-05	0.00023	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—SST—Barrett's esophagus	2.36e-05	0.000225	CbGpPWpGaD
Carvedilol—ADRB1—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.28e-05	0.000217	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling by GPCR—CXCL8—Barrett's esophagus	2.27e-05	0.000216	CbGpPWpGaD
Carvedilol—ADRA2B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.26e-05	0.000215	CbGpPWpGaD
Carvedilol—ADRB2—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.23e-05	0.000212	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	2.2e-05	0.00021	CbGpPWpGaD
Carvedilol—ADRA2B—Hemostasis—TP53—Barrett's esophagus	2.19e-05	0.000209	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—RELA—Barrett's esophagus	2.19e-05	0.000208	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—SLC9A1—Barrett's esophagus	2.18e-05	0.000208	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—RELA—Barrett's esophagus	2.18e-05	0.000208	CbGpPWpGaD
Carvedilol—ADRA2C—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.11e-05	0.000201	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	2.09e-05	0.000199	CbGpPWpGaD
Carvedilol—ADRA1B—GPCR downstream signaling—CXCL8—Barrett's esophagus	2.08e-05	0.000198	CbGpPWpGaD
Carvedilol—ADRB1—Signaling by GPCR—CXCL8—Barrett's esophagus	2.07e-05	0.000197	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—CXCL8—Barrett's esophagus	2.06e-05	0.000196	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—SLC9A1—Barrett's esophagus	2.06e-05	0.000196	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—CXCL8—Barrett's esophagus	2.06e-05	0.000196	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling by GPCR—CXCL8—Barrett's esophagus	2.05e-05	0.000195	CbGpPWpGaD
Carvedilol—ADRA2C—Hemostasis—TP53—Barrett's esophagus	2.05e-05	0.000195	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—SLC9A1—Barrett's esophagus	2.04e-05	0.000194	CbGpPWpGaD
Carvedilol—ADRB2—Signaling by GPCR—CXCL8—Barrett's esophagus	2.03e-05	0.000193	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling by GPCR—CXCL8—Barrett's esophagus	1.92e-05	0.000183	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling by GPCR—CXCL8—Barrett's esophagus	1.89e-05	0.00018	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—CYP26A1—Barrett's esophagus	1.87e-05	0.000178	CbGpPWpGaD
Carvedilol—ADRA1A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.84e-05	0.000176	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—APC—Barrett's esophagus	1.82e-05	0.000174	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—Barrett's esophagus	1.79e-05	0.00017	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PPARG—Barrett's esophagus	1.77e-05	0.000169	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PPARG—Barrett's esophagus	1.77e-05	0.000169	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—SLC9A1—Barrett's esophagus	1.74e-05	0.000166	CbGpPWpGaD
Carvedilol—ADRA2A—GPCR downstream signaling—CXCL8—Barrett's esophagus	1.71e-05	0.000163	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.67e-05	0.00016	CbGpPWpGaD
Carvedilol—ADRA2A—Hemostasis—TP53—Barrett's esophagus	1.66e-05	0.000159	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—APC—Barrett's esophagus	1.66e-05	0.000158	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—APC—Barrett's esophagus	1.65e-05	0.000157	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.64e-05	0.000157	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—APC—Barrett's esophagus	1.62e-05	0.000155	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling by GPCR—CXCL8—Barrett's esophagus	1.56e-05	0.000148	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—APC—Barrett's esophagus	1.54e-05	0.000146	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—APC—Barrett's esophagus	1.51e-05	0.000144	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PPARG—Barrett's esophagus	1.44e-05	0.000137	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—RELA—Barrett's esophagus	1.42e-05	0.000136	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Barrett's esophagus	1.41e-05	0.000134	CbGpPWpGaD
Carvedilol—ADRA2C—Metabolism—PTGS2—Barrett's esophagus	1.4e-05	0.000133	CbGpPWpGaD
Carvedilol—PTGS1—Metabolism—PTGS2—Barrett's esophagus	1.39e-05	0.000133	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—SLC9A1—Barrett's esophagus	1.34e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—APC—Barrett's esophagus	1.34e-05	0.000128	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—CXCL8—Barrett's esophagus	1.34e-05	0.000128	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PPARG—Barrett's esophagus	1.32e-05	0.000126	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—RELA—Barrett's esophagus	1.3e-05	0.000124	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—RELA—Barrett's esophagus	1.29e-05	0.000122	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—RELA—Barrett's esophagus	1.27e-05	0.000121	CbGpPWpGaD
Carvedilol—ADRB3—Signaling Pathways—TP53—Barrett's esophagus	1.26e-05	0.00012	CbGpPWpGaD
Carvedilol—VEGFA—Signaling Pathways—TP53—Barrett's esophagus	1.26e-05	0.00012	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—APC—Barrett's esophagus	1.25e-05	0.000119	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PPARG—Barrett's esophagus	1.25e-05	0.000119	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—CXCL8—Barrett's esophagus	1.22e-05	0.000117	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—CXCL8—Barrett's esophagus	1.21e-05	0.000115	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—RELA—Barrett's esophagus	1.2e-05	0.000114	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—CXCL8—Barrett's esophagus	1.2e-05	0.000114	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—RELA—Barrett's esophagus	1.18e-05	0.000113	CbGpPWpGaD
Carvedilol—ADRA2A—Metabolism—PTGS2—Barrett's esophagus	1.13e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—CXCL8—Barrett's esophagus	1.13e-05	0.000108	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—CXCL8—Barrett's esophagus	1.11e-05	0.000106	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—RELA—Barrett's esophagus	1.05e-05	0.0001	CbGpPWpGaD
Carvedilol—CYP2E1—Metabolism—PTGS2—Barrett's esophagus	1.04e-05	9.92e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PPARG—Barrett's esophagus	9.97e-06	9.49e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—CXCL8—Barrett's esophagus	9.89e-06	9.43e-05	CbGpPWpGaD
Carvedilol—CYP1A1—Metabolism—PTGS2—Barrett's esophagus	9.81e-06	9.35e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—RELA—Barrett's esophagus	9.76e-06	9.29e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PPARG—Barrett's esophagus	9.39e-06	8.95e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PPARG—Barrett's esophagus	9.31e-06	8.87e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—CXCL8—Barrett's esophagus	9.19e-06	8.76e-05	CbGpPWpGaD
Carvedilol—ADRA1D—Signaling Pathways—TP53—Barrett's esophagus	8.24e-06	7.85e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PPARG—Barrett's esophagus	7.96e-06	7.58e-05	CbGpPWpGaD
Carvedilol—ABCB1—Metabolism—PTGS2—Barrett's esophagus	7.84e-06	7.47e-05	CbGpPWpGaD
Carvedilol—ADRB1—Signaling Pathways—TP53—Barrett's esophagus	7.5e-06	7.15e-05	CbGpPWpGaD
Carvedilol—ADRA2B—Signaling Pathways—TP53—Barrett's esophagus	7.44e-06	7.08e-05	CbGpPWpGaD
Carvedilol—CYP2D6—Metabolism—PTGS2—Barrett's esophagus	7.39e-06	7.04e-05	CbGpPWpGaD
Carvedilol—ADRB2—Signaling Pathways—TP53—Barrett's esophagus	7.34e-06	6.99e-05	CbGpPWpGaD
Carvedilol—CYP2C9—Metabolism—PTGS2—Barrett's esophagus	7.32e-06	6.98e-05	CbGpPWpGaD
Carvedilol—ADRA2C—Signaling Pathways—TP53—Barrett's esophagus	6.95e-06	6.62e-05	CbGpPWpGaD
Carvedilol—ADRA1B—Signaling Pathways—TP53—Barrett's esophagus	6.84e-06	6.51e-05	CbGpPWpGaD
Carvedilol—CYP1A2—Metabolism—PTGS2—Barrett's esophagus	6.26e-06	5.96e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PPARG—Barrett's esophagus	6.14e-06	5.85e-05	CbGpPWpGaD
Carvedilol—ADRA1A—Signaling Pathways—TP53—Barrett's esophagus	6.07e-06	5.78e-05	CbGpPWpGaD
Carvedilol—ADRA2A—Signaling Pathways—TP53—Barrett's esophagus	5.64e-06	5.37e-05	CbGpPWpGaD
Carvedilol—CYP3A4—Metabolism—PTGS2—Barrett's esophagus	4.83e-06	4.6e-05	CbGpPWpGaD
